Sign in

You're signed outSign in or to get full access.

Scott Mund

Director at HOULIHAN LOKEYHOULIHAN LOKEY
Board

About Scott Mund

R. Scott “Scott” Mund is an independent Class II director of Houlihan Lokey, appointed effective October 1, 2025, with a term through the 2026 Annual Meeting of Stockholders . He is a Deloitte LLP partner (joined 2002) and previously spent over 15 years at Arthur Andersen, culminating in partner; he holds a bachelor’s degree from UCLA and is a certified public accountant . Upon appointment he was named to HLI’s Nominating and Corporate Governance Committee and deemed independent under NYSE rules, with no related‑party transactions requiring disclosure under Item 404(a) .

Past Roles

OrganizationRoleTenureCommittees/Impact
Deloitte LLPPartner2002–presentServed two terms on Deloitte’s U.S. Board; worked with executive leadership on long‑term planning, financial management, and investment strategy .
Arthur AndersenIncreasing responsibility → Partner~15+ years, ending prior to 2002Audit/tax advisory background; promoted to partner .

External Roles

OrganizationRoleTenureCommittees/Impact
Deloitte U.S. Board of Directors (private)Director (two terms)Not disclosedFinance/Audit, Global, Strategic Investment, and Partner Earnings & Benefits (Talent) Committees .

Board Governance

  • Classification and term: Appointed as an independent Class II director effective October 1, 2025; elected to serve until the 2026 Annual Meeting and until a successor is duly elected and qualifies .
  • Committee assignment: Member, Nominating and Corporate Governance Committee (appointed at time of board appointment) .
  • Independence and conflicts: Board determined independence under NYSE rules; no Item 404(a) related‑party transactions disclosed for Mund .
  • Board structure context: HLI maintains a classified board (three classes with staggered terms) as described in the 2025 Proxy .
  • Controlled company status: HL Voting Trust controls a majority of voting power; following the 2025 Annual Meeting the board would no longer have a majority of independent directors, though HLI states it complies with non‑controlled criteria at present .
  • Board/committee cadence and attendance baseline (FY2025 context): 4 Board meetings; Audit 8; Compensation 6; Nominating & Corporate Governance 4; each director attended at least 75% of meetings in FY2025 (note: Mund joined after FY2025) .
  • Independent director sessions: Lead Independent Director presides over executive sessions of independent directors not less than annually .

Fixed Compensation

ComponentAmount/TermsNotes
Annual cash retainer (outside director)$100,000Reflected as “Fees Earned or Paid in Cash” for each outside director in FY2025 .
Annual Director Award (equity)$100,000 (fully vested Class A common stock)Dollar‑denominated grant; shares determined using 10‑day average after earnings; pro‑rated for partial year .
Committee Chair Award – Audit$50,000 (fully vested stock)Paid to Audit Chair; e.g., chair received $50,000 in FY2025 .
Committee Chair Award – Comp; Nominating & Corporate Governance$30,000 each (fully vested stock)Paid to committee chairs; e.g., FY2025 chair recipients received $30,000 .
New Director Award (Mund)$100,000 restricted Class A stockGranted at commencement; vests in substantially equal installments on the 1st, 2nd, and 3rd anniversaries of grant, subject to service .
Independent Director Stock Ownership Policy4x annual cash compensationAnticipated to be met by about 4th anniversary; policy applies to outside directors .

Performance Compensation

Not applicable for outside directors: the program provides fully vested annual stock awards and time‑based restricted stock for new directors; there are no disclosed performance‑conditioned metrics or bonuses for directors .

MetricTargetActual/StatusNotes
Performance‑conditioned equity/bonus (Director)None disclosedN/AAnnual awards are fully vested stock; new director award is time‑vested .

Other Directorships & Interlocks

TypeCompany/OrganizationRoleNotes
Public company directorshipsNot disclosedNo other public company boards disclosed in the HLI appointment 8‑K .
Private/professional boardDeloitte U.S. BoardDirector (two terms)Committees: Finance/Audit, Global, Strategic Investment, Partner Earnings & Benefits .
Related‑party exposure8‑K states no Item 404(a) transactions for Mund at appointment .

Expertise & Qualifications

  • Nearly four decades advising public and private multinationals on M&A, cross‑border taxation, corporate governance, and business transformation, supporting board‑level oversight needs .
  • CPA with audit/financial oversight experience; service on finance/audit and strategic committees at Deloitte U.S. Board indicates strong committee‑readiness .
  • Education: Bachelor’s degree, UCLA .

Equity Ownership

DateForm/EventSecurityAmount/StatusOwnership FormNotes
Oct 1, 2025Board appointmentAppointed independent Class II director; committee assignment to Nominating & Corporate Governance Committee .
Oct 1, 2025New Director AwardRestricted Class A stock$100,000 grant value; vests 1/3 on 1st, 2nd, 3rd anniversariesDirect (subject to vesting)Granted under Director Compensation Program at commencement of service .
Oct 14, 2025Form 3All classesNo securities beneficially ownedInitial statement of beneficial ownership filed; reported no holdings at that time .

Insider Trades and Section 16 Filings

FilingFiledSummaryNotes
Form 3 (Initial Statement of Beneficial Ownership)Oct 14, 2025Reported no securities beneficially ownedIncludes Power of Attorney authorizing officers to file Section 16 reports .

Governance Assessment

  • Positives for investor confidence:

    • Independent director with deep CPA/M&A/tax and governance expertise; immediate placement on the Nominating & Corporate Governance Committee strengthens board process oversight .
    • No related‑party transactions under Item 404(a) at appointment; independence under NYSE rules explicitly stated .
    • Director compensation structure is balanced between fixed cash ($100,000 retainer) and equity ($100,000 annual award), aligning directors with shareholders; policy targets meaningful ownership at 4x cash retainer .
  • Watch items / potential red flags:

    • Controlled company status means HLI may operate without a majority‑independent board after the 2025 Annual Meeting despite current compliance; governance protections differ from non‑controlled firms .
    • Mund’s current Deloitte partnership suggests monitoring for any Deloitte engagements with HLI; while no Item 404(a) transactions were disclosed and independence was affirmed, ongoing auditor/advisor relationships could create perceived conflicts if they were to arise .
    • As a new director post‑FY2025, individual attendance/engagement data are not yet available; board‑wide FY2025 attendance was at least 75% for all directors, providing a baseline expectation (Mund not in scope for FY2025) .